Who is eligible for clinical trial NCT05556772?

Participants must meet the protocol's inclusion criteria for Malignant Female Reproductive System Neoplasm. The stated age range is 25 Years to 49 Years. Confirm all requirements with the study coordinator.

Does clinical trial NCT05556772 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2025-12-11

Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic (NCT05556772)

Estudio Oportunidad: Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic

🔵 Active, Not Recruiting Observational / Diagnostic 🩺 Clinical Procedure Protocol Sponsor: Fred Hutchinson Cancer Center

🩺 Plain-English Summary (8th-Grade Level)

This study compares different screening approaches to detect abnormal cell growth on the cervix that could be an early sign of cervical cancer. The lesions are caused by an infection of human papillomavirus, also called HPV. Using new methods to detect HPV may help doctors find ways to improve cervical cancer screening for women living with human immunodeficiency virus (HIV) in the Dominican Republic and in other countries.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (5 items).

Location: Instituto Dermatológico Dominicano y Cirugía de Piel (IDCP) "Dr. Huberto Bogaert Diaz" — Santo Domingo

Age range: 25 Years to 49 Years

🧪 Interventions in This Study

Biospecimen Collection (PROCEDURE)
Interview (OTHER)

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Women ages 25 - 49 years old will be eligible to participate in the study
Women living with HIV who have an intact cervix
Intent to reside in the Santo Domingo area
Ability to attend routine study visits at IDCP for at least 24 months during the study. If women report that they anticipate relocating in the subsequent 24 months or anticipate difficulty attending study visits they will not be eligible
Ability to understand the study timeline and procedures and the willingness to complete the informed consent process are also inclusion criteria

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
Women with a prior diagnosis of cervical cancer or a history of treatment for cervical precancerous lesions (CIN2+) will be excluded
Women with significant physical, mental, or social conditions that would limit participation with study procedures will not be eligible for the study
Women who are pregnant or report an intent to become pregnant in the subsequent 3 months will not be eligible for the study
Women who have no history of vaginal sexual exposure will not be eligible for the study

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

Instituto Dermatológico Dominicano y Cirugía de Piel (IDCP) "Dr. Huberto Bogaert Diaz" — Santo Domingo,

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Malignant Female Reproductive System Neoplasm

An Individualized Online Home-Based Exercise Program for Improving Symptoms in Gynecologic Cancer Survivors — Atlanta, Georgia
Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer — Houston, Texas
e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study — Duarte, California
Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery — Rochester, Minnesota
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers — Baltimore, Maryland

Explore by condition: All Malignant Female Reproductive System Neoplasm clinical trials

💡 How to Participate

Check the checklist above to see if you may qualify.
Review the official NIH record below to find the coordinating site.
Ask about the visit schedule, what is covered at no cost, and any travel support.
Confirm with your own doctor before making a decision.

🏛️ View Official NIH Record ↗